Evotec, in collaboration with Olink, offers advanced high-multiplex targeted protein panel analysis to support translational biomarker discovery in drug development. Using Olink’s high-throughput immunoassay technology, researchers can measure multiple proteins with high sensitivity and specificity using minimal sample volumes (1–2 µL). Olink platforms include Olink® Target96, Olink® Target 48, and Olink® Flex, covering a broad range of proteins relevant to disease areas like oncology, neurology, and inflammation. The service is designed for exploratory biomarker discovery, clinical trial support, and precision assay development.